Beximco Pharma

History

Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. Today, Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US.

In May 2020, the company introduced the world's first generic remdesivir for COVID-19 treatment. Beximco Pharma became the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along with Eskayef Pharmaceuticals. Beximco Pharma's branded generic version of molnupiravir is being marketed as Emorivir.

Factories

Beximco Pharma manufacturing facilities are spread across a 20 acre site located in Dhaka, Bangladesh. The facilities consist of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.

Exports

In August 2007, Beximco exported its medicines to the Philippines, the 5th country of the 10-member Association of South East Asian Nations (ASEAN) to import Beximco's drugs.

References

References

1. "Beximco Pharmaceuticals Ltd.". WSJ.
2. "Beximco Pharma Annual Report 2018-19".
3. (5 April 2006). "BD firm plans to export version of Tamiflu". [[Daily Times (Pakistan).
4. "Bangladesh forays into US market with Beximco Pharma". [[bdnews24.com]].
5. "Beximco Pharma Q3 revenue up".
6. "US FDA approves Beximco Pharma's blood pressure drug". [[Dhaka Tribune]].
7. (21 May 2020). "Beximco introduces remdesivir for Covid-19 treatment". The Daily Star.
8. "Beximco Pharma introduces world's first generic Remdesivir for COVID-19 treatment". [[The Financial Express (Bangladesh).
9. Siddiqui, Zeba. (5 May 2020). "Exclusive: Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO". [[Reuters]].
10. Pilla, Viswanath. (December 30, 2021). "Bangladesh drug maker Beximco launches world's first generic of Pfizer's COVID antiviral". [[The Economic Times]].
11. (January 20, 2022). "Beximco Pharma gets license for oral anti-Covid drug". [[The Business Standard]].
12. (June 26, 2024). "Merck’s COVID-19 pill molnupiravir hits Bangladesh markets". [[The Financial Express (Bangladesh).
13. (April 30, 2024). "Beximco Pharma’s Q3 profits soar 51%". The Daily Star.